600713.SH
南京医药
SSE · Healthcare · Medical - Distribution · CN
CNY 5.16
−0.77%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
8.2x
Market Cap
CNY 6.75B
MomentumView details →
1D Return
−0.77%
YTD Return
−3.66%
RSI (14)
51.6
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
8.2x
Market Cap
CNY 6.75B
RSI (14)
51.6
MomentumView details →
1D Return
−0.77%
YTD Return
−3.66%
Similar companies
Latest newsMore news →
Nanjing Pharmaceutical Co., Ltd. announced a cash dividend of 0.9 yuan per 10 shares (tax included), with total distribution of 118 million yuan based on total share capital of 1.308 billion shares.8d agoNanjing Pharmaceutical Co., Ltd. announced its first-half 2026 results: revenue of 27.823 billion yuan, down 0.52% year-on-year; net profit attributable to shareholders of 294 million yuan, up 1.10% year-on-year.8d ago